Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-64,245
Closed -$436K 755
2020
Q3
$436K Sell
64,245
-95,361
-60% -$689K 0.01% 571
2020
Q2
$1.1M Buy
159,606
+116,105
+267% +$922K 0.02% 417
2020
Q1
$370K Hold
43,501
0.01% 638
2019
Q4
$487K Sell
43,501
-92,245
-68% -$877K 0.01% 656
2019
Q3
$1.15M Buy
135,746
+6,793
+5% +$55.3K 0.02% 498
2019
Q2
$1.12M Buy
128,953
+2,039
+2% +$18K 0.02% 507
2019
Q1
$954K Buy
126,914
+68,700
+118% +$449K 0.01% 542
2018
Q4
$391K Buy
+58,214
New +$373K 0.01% 684

Other funds holding TRMD

Segall Bryant & Hamill's TRMD Position: Q4 2020 in Review

Segall Bryant & Hamill sold out of TORM (TRMD) in Q4 2020, closing a stake of 64,245 shares — an estimated $436K sold.

Segall Bryant & Hamill first reported a position in TRMD in Q4 2018 and held it in 8 quarters. The position peaked at $1.15M in Q3 2019. 21 funds tracked by Wall St. Rank hold TRMD as of Q4 2020.

  • Segall Bryant & Hamill reported no remaining TORM position as of Q4 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 64,245 TORM shares in Q4 2020, an estimated $436K.
  • Segall Bryant & Hamill first reported a position in TORM in Q4 2018 and held it in 8 quarters.
  • Segall Bryant & Hamill's TORM position peaked at $1.15M in Q3 2019.
  • 21 funds tracked by Wall St. Rank held TORM as of Q4 2020.

Based on Segall Bryant & Hamill's 13F filing for Q4 2020, filed 12 Feb 2021.